Doctor Hans-Eckart Sarnighausen

Back

Doctor Hans-Eckart Sarnighausen

Praxis, Lueneburg (Germany)

Member of:

Born 1967 in Lüneburg, Germany University of Kiel and Lübeck 1988-94, MD 1995 Postdoc in Basel, Mainz, Hildesheim 1995-2002 Internal Medicine and Diabetology 2001 Cardiology Specialisation in Bad Bevensen 2002-2004 Subspecialisation in Cardiology 2005 Subspecialisation in Social Medicine 2010 Private Practice since 2005, specialiced in Cardiology & Diabetology Clinical Investigations in Heart Failure, Atrial Fibrillation, Diabetology Expert witness in Social Medicine in Cardiology & Diabetology

Presentations

May oral anticoagulation be considered for secondary prevention after coronary artery bypass operation complicated with postoperative atrial fibrillation in a high-risk patient?

Event: ESC Congress 2022

Topic: Clinical

Session: Atrial fibrillation

Access

Immediate implementation of three 2019 european society of cardiology guidelines in daily practice

Event: ESC Congress 2021 - The Digital Experience

Topic: Lipids

Session: Risk Factors and Prevention ePosters

Access

Secondary prophylaxis after cardiogenic shock in a 47-years old man presenting with STEMI with positive family history for sudden cardiac death (father) and very high Lp(a) as single cardiovascular risk factor.

Event: Heart Failure 2021

Topic: Clinical

Session: Clinical Case session

Access

Doctor Hans-Eckart Sarnighausen

Biography

Contributor content

May oral anticoagulation be considered for secondary prevention after coronary artery bypass operation complicated with postoperative atrial fibrillation in a high-risk patient?

Immediate implementation of three 2019 european society of cardiology guidelines in daily practice

Secondary prophylaxis after cardiogenic shock in a 47-years old man presenting with STEMI with positive family history for sudden cardiac death (father) and very high Lp(a) as single cardiovascular risk factor.

ESC 365 is supported by